Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimates
2007

Understanding Antagonist Affinity in GPCRs

publication Evidence: moderate

Author Information

Author(s): Jillian G. Baker, Stephen J. Hill

Primary Institution: Institute of Cell Signalling, Medical School, Nottingham, UK

Hypothesis

Can antagonist affinity measurements vary depending on the agonist and experimental conditions?

Conclusion

Antagonist affinities can differ based on the agonist used and the specific receptor conformation.

Supporting Evidence

  • Antagonist affinities can vary depending on the agonist used.
  • Different GPCR conformations can lead to different pharmacological profiles.
  • Allosteric ligands can influence antagonist binding.
  • Antagonist effects can differ based on the specific signalling pathway activated.

Takeaway

Sometimes, the way a medicine works can change depending on what other medicines are around it or how the body is using it.

Methodology

The study discusses various mechanisms affecting antagonist affinity in GPCRs, including allosterism and different G protein coupling.

Limitations

The study primarily discusses theoretical implications without presenting new experimental data.

Digital Object Identifier (DOI)

10.1016/j.tips.2007.06.011

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication